.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
India recently launched a groundbreaking global clinical study evaluating Ayurveda in TB treatment as a supportive therapy. This initiative aims to scientifically validate traditional medicine alongside modern regimens. Consequently, researchers will monitor how these combined therapies influence patient recovery and long-term health outcomes. Furthermore, the collaboration between the Ministry of Ayush and the Department of Biotechnology marks a significant milestone in integrative healthcare.
The study involves 1,250 newly diagnosed tuberculosis patients across eight major institutions. Participants will receive standard anti-tuberculosis treatment alongside a defined Ayurveda regimen. Additionally, investigators will track changes in body weight and nutritional status. They will also assess disease progression and the overall quality of life for participants. Safety and tolerability remain primary endpoints throughout this trial.
Many patients experience persistent weakness even after completing successful antibiotic courses. Therefore, Union Minister Jitendra Singh emphasized the need for host-directed therapies. India's rich heritage of Ayurveda offers unique opportunities to boost immunity and enhance nutrition. This holistic approach might bridge the gap in current care protocols. Moreover, it aligns with India's goal of eliminating TB by 2025.
India currently accounts for nearly 25 percent of the global TB burden. However, the nation saw a 21 percent reduction in incidence between 2015 and 2024. This drop reflects the success of early diagnosis and universal drug testing. Thus, the government continues to strengthen patient-centric care under the National TB Elimination Programme. This clinical trial supports these ongoing efforts effectively.
Q1: What is the primary goal of this clinical study?
The study aims to evaluate Ayurveda as an adjunct therapy to improve nutritional outcomes, immunity, and quality of life in TB patients.
Q2: How many patients are participating in the trial?
The trial will enrol 1,250 newly diagnosed TB patients across eight different institutions in India.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
India starts a clinical study on 1,250 patients to evaluate Ayurveda as an adjunct to TB treatment for better recovery, nutrition, and overall quality of li...
4 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
